GGrantIndex
← Leaderboards

Geoffrey Douglas Barnes

University Of Michigan At Ann Arbor

$4,245,308
Attributed
$6,620,984
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201725
$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,786,245 · 5
AHRQ$2,834,739 · 2

By mechanism

R18$2,834,739 · 2
R01$2,246,118 · 1
K01$842,400 · 1
K12$408,642 · 1
R03$156,000 · 1
K24$133,085 · 1

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Michigan

Research focus

MichiganDesignOralPharmaceutical PreparationsHemorrhageAnticoagulantsEvaluationInterviewImplementation ScienceDecision MakingAdverse EventEvidence BaseCaringLifeTheoriesMapsSiteStructureHealth SystemSuccessAnticoagulationResourcesAdherenceSafety

Grant awards (18)

Michigan Emergency Department Improvement Collaborative AltERnaTives to admission for Pulmonary Embolism (MEDIC ALERT PE) Study$774,699
R01 · FY2025 · HL · contact PI
Developing Implementation Science Expertise in Cardiovascular Health Services Research$133,085
K24 · FY2025 · HL · contact PI
Michigan Emergency Department Improvement Collaborative AltERnaTives to admission for Pulmonary Embolism (MEDIC ALERT PE) Study$763,210
R01 · FY2024 · HL · contact PI
Michigan Emergency Department Improvement Collaborative AltERnaTives to admission for Pulmonary Embolism (MEDIC ALERT PE) Study$708,209
R01 · FY2023 · HL · contact PI
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use$448,896
R18 · FY2023 · HS · contact PI
Improving Safe Use of Direct Oral Anticoagulants: A Population Health Approach$487,459
R18 · FY2022 · HS · contact PI
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use$448,991
R18 · FY2022 · HS · contact PI
Improving Safe Use of Direct Oral Anticoagulants: A Population Health Approach$499,545
R18 · FY2021 · HS · contact PI
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use$449,999
R18 · FY2021 · HS · contact PI
Training to Advance Care Through Implementation Science in Cardiac And Lung Illnesses (TACTICAL)$408,642
K12 · FY2021 · HL
Developing an Implementation Strategy to Improve Peri-procedural Anticoagulation Management for Patients with Atrial Fibrillation$168,480
K01 · FY2021 · HL · contact PI
Development of computer aided decision support and EHR alerts for DOAC prescribing$78,000
R03 · FY2021 · HL · contact PI
Improving Safe Use of Direct Oral Anticoagulants: A Population Health Approach$499,849
R18 · FY2020 · HS · contact PI
Developing an Implementation Strategy to Improve Peri-procedural Anticoagulation Management for Patients with Atrial Fibrillation$168,480
K01 · FY2020 · HL · contact PI
Development of computer aided decision support and EHR alerts for DOAC prescribing$78,000
R03 · FY2020 · HL · contact PI
Developing an Implementation Strategy to Improve Peri-procedural Anticoagulation Management for Patients with Atrial Fibrillation$168,480
K01 · FY2019 · HL · contact PI
Developing an Implementation Strategy to Improve Peri-procedural Anticoagulation Management for Patients with Atrial Fibrillation$168,480
K01 · FY2018 · HL · contact PI
Developing an Implementation Strategy to Improve Peri-procedural Anticoagulation Management for Patients with Atrial Fibrillation$168,480
K01 · FY2017 · HL · contact PI